Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes

Journal of Molecular Biology

Volumn 259, Issue 4, 1996, Pages 632-644

  Kronenwett, Ralf ^a,b   Haas, Rainer ^a,b   Sczakiel, Georg ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Klin Kooperationseinheit Molec H   (Germany)

^c Abt 620   (Germany)

Author keywords

Antisense nucleic acids; bcr abl; Hammerhead ribozymes; In vitro selection; RNA RNA annealing

Indexed keywords

BCR ABL PROTEIN; COMPLEMENTARY RNA; OLIGODEOXYNUCLEOTIDE; RIBOZYME;

ARTICLE; CHRONIC MYELOID LEUKEMIA; HUMAN; HUMAN CELL; KINETICS; ONCOGENE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

EID: 0030596527     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1996.0345     Document Type: Article

References (51)

1. Barrio, J. R., Barrio, M. C., Leonard, N. J., England, T. E. & Uhlenbeck O. C. (1978). Synthesis of modified nucleoside 3′,5′-biphosphates and their incorporation into oligoribonucleotides with T4 RNA ligase. Biochemistry, 17, 2077-2081.
2. Bernards, A., Rubin, C. M., Westbrook, C. A., Paskind, M. & Baltimore, D. (1987). The first intron in the human c-abl gene is at least 200 kilobases long and is a target for translocations in chronic myelogenous leukemia. Mol. Cell. Biol. 7, 3231-3236.
3. Chomczynski, P. & Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal. Biochem. 162, 156-159.
4. Daley, G. Q., Van Etten, R. A. & Baltimore, D. (1990). Induction of chronic myelogenous leukemia in mice by the P210 bcr/abl gene of the Philadelphia chromosome. Science, 247, 824-830.
5. Heisterkamp, N., Stam, K., Groffen, J., de Klein, A. & Grosveld, G. (1985). Structural organization of the bcr gene and its role in the Ph' translocation. Nature, 315, 758-761.
6. Hélène, C. & Toulmé, J. J. (1990) Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim. Biophys. Acta, 1049, 99-125.
7. Homann, M., Tzortzakaki, S., Rittner, K., Sczakiel, G. & Tabler, M. (1993a) Incorporation of the catalytic domain of a hammerhead ribozyme enhances the inhibitory effect on the replication of the human immunodeficiency virus type 1. Nucl. Acids Res. 21, 2809-2814.
8. Homann, M., Rittner, K. & Sczakiel, G. (1993b). Complementary large loops determine the rate of duplex formation in vitro in case of an effective antisense RNA directed against the human immunodeficiency virus type 1. J. Mol. Biol. 233, 7-15.
9. James, W. & Al-Shamkhani, A. (1995). RNA enzymes as tools for gene ablation. Curr. Opin. Biotechnol. 6, 44-49.
10. Kaebisch, A., Perenyi, L., Seay, U., Lohmeyer, J. & Pralle, H. (1994). Unmodified phosphodiester antisense oligodeoxynucleotides to the BCR-ABL junction do not suppress Philadelphia-positive clonogenic cells. Acta Haematol. 92, 190-196.
11. Kearney, P., Wright, L. A., Milliken, S. & Biggs, J. C. (1995). Improved specificity of ribozyme-mediated cleavage of bcr-abl mRNA. Exp. Hematol. 21, 986-989.
12. Kelliher, M. A., McLaughlin, J., Witte, O. N. & Rosenberg, N. (1990). Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL. Proc. Natl Acad. Sci. USA, 87, 6649-6653.
13. Konopka, J. B. & Witte, O. N. (1985). Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products. Mol. Cell Biol. 5, 3116-3123.
14. Kurzrock, R., Gutterman, J. U. & Talpaz, M. (1988). The molecular genetics of Philadelphia chromosome-positive leukemias. N. Engl. J. Med. 319, 990-998.
15. Lozzio, C. B. & Lozzio, B. B. (1975). Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood, 45, 321-334.
16. Maekawa, T., Kimura, S., Hirakawa, K., Murakami, A., Zon, G. & Abe, T. (1995). Sequence specificity on the growth suppression and induction of apoptosis of chronic myeloid leukemia cells by bcr-abl anti-sense oligodeoxynucleoside phosphorothioates. Int. J. Cancer, 62, 63-69.
17. Marshall, P., Thompson, J. B. & Eckstein, F. (1994). Inhibition of gene expression with ribozymes. Cell. Mol. Neurobiol. 14, 5523-5538.
18. Martiat, P., Lewalle, P., Taj, A. S., Philippe, M., Larondelle, Y., Vaerman, J. L., Wildmann, C., Goldman, J. M. & Michaux, J. L. (1993). Retrovirally transduced antisense sequences stably suppress p210 bcr-abl expression and inhibit the proliferation of BCR/ABL-containing cell lines. Blood, 81, 502-509.
19. Maru, Y. & Witte, O. N. (1991). The BCR gene encodes a novel serine/threonine kinase activity within a single exon. Cell, 67, 459-468.
20. Maru, Y., Peters, K. L., Afar, D. E. H., Shibuya, M., Witte, O. N. & Smithgall, T. E. (1995). Tyrosine phosphorylation of BCR by FPS/FES protein-tyrosine kinases induces association of BCR with GRB-2/SOS. Mol. Cell. Biol. 15, 835-842.
21. Nellen, W. & Sczakiel, G. (1996). Mechanisms of antisense RNA-mediated gene silencing, Mol. Biotechnol. In the press.
22. Nichols, G. L. (1995). Antisense oligonucleotides as therapeutic agents for chronic myelogenous leukemia. Antisense Res. Dev. 5, 67-69.
23. O'Brien, S. G., Kirkland, M. A., Melo, J. V., Rao, M. H., Davidson, R. J., McDonald, C. & Goldman, J. M. (1994). Antisense bcr-abl oligomers cause non-specific inhibition of chronic myeloid leukemia cell lines. Leukemia, 8, 2156-2162.
24. Pachuk, C. J., Yoon, K., Moelling, K. & Coney, L. R. (1994). Selective cleavage of bcr-abl chimeric RNAs by a ribozyme targeted to non-contiguous sequences. Nucl. Acids Res. 22, 301-307.
25. Pontius, B. W. (1993). Close encounters: why unstructured, polymeric domains can increase rates of specific macromolecular association. Trends Biochem. Sci. 18, 181-186.
26. Pontius, B. W. & Berg, P. (1990). Renaturation of complementary DNA strands mediated by purified mammalian heterogenous nuclear ribonucleoprotein A1 protein: implications for a mechanism for rapid molecular assembly. Proc. Natl Acad. Sci. USA, 87, 8403-8407.
27. Rittner, K., Burmester, C. & Sczakiel, G. (1993). In vitro selection of fast-hybridizing and effective antisense RNAs directed against the human immunodeficiency virus type 1. Nucl. Acids Res. 21, 1381-1387.
28. Sambrook, J., Fritsch, E. F. & Maniatis, F. (1989). Molecular Cloning: a Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Habor, NY.
29. Sawyers, C. L., McLaughlin, J., Goga, A., Havlik, M. & Witte, O. N. (1994). The nuclear tyrosine kinase c-abl negatively regulates cell growth. Cell, 77, 121-131.
30. Schreiber, E., Matthias, P., Müller, M. M. & Schaffner, W. (1989). Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucl. Acids Res. 17, 6419.
31. Schwab, G., Chavany, C., Duroux, I., Goubin, G., Lebeau, J., Hélène, C. & Saison-Behmoaras, T. (1994). Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation in nude mice and tumorigeneity in nude mice. Proc. Natl Acad. Sci. USA, 91, 10460-10464.
32. Sczakiel, G. (1996). Hammerhead ribozymes with long antisense flanks: domain structure and binding kinetics. In Nucleic Acids and Molecular Biology (Eckstein, F. & Lilley, D. M. J., eds), Springer-Verlag, Heidelberg. In the press.
33. Sczakiel, G. & Nedbal, W. (1995). The potential of ribozymes as antiviral agents. Trends Microbiol. 3, 213-217.
34. Sczakiel, G., Homann, M. & Rittner, K. (1993). Computer-aided search for effective antisense RNA target sequences of the human immunodeficiency virus type 1. Antisense Res. Dev. 3, 45-52.
35. Shtivelman, E., Lifshitz, B., Gale, R. P., Roe, B. A. & Canaani, E. (1986). Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell, 47, 277-284.
36. 1 leukemic cells by exposure to bcr/abl antisense oligodeoxynucleotides combined with mafosfamide. J. Clin. Invest. 92, 194-202.
37. 1 leukemia cell growth in mice by BCR/ABL antisense oligodeoxynucleotide. Proc. Natl Acad. Sci. USA, 91, 4504-4508.
38. Smetsers, T. F. C. M., Skorski, T., van de Locht, L. T. F., Wessels, H. M. C., Pennings, A. H. M., de Witte, T., Calabretta, B. & Mensink, E. J. B. M. (1994). Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173. Leukemia, 8, 129-140.
39. Smetsers, T. F. C. M., van de Locht, L. T. F., Pennings, A. H. M., Wessels, H. M. C., de Witte, T. M. & Mensink, E. J. B. M. (1995). Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular bcr-abl protein levels. Leukemia, 9, 118-130.
40. Snyder, D. S., Wu, Y., Wang, J. L., Rossi, J. J., Swiderski, P., Kaplan, B. E. & Forman, S. J. (1993). Ribozyme-mediated inhibition of bcr-abl gene expression in a Philadelphia chromosome-positive cell line. Blood, 82, 600-605.
41. Southern, E. M., Maskos, U. & Elder, K. (1992). Analyzing and comparing nucleic acid sequences by hybridization to arrays of oligonucleotides: evaluation using experimental models. Genomics, 13, 1008-1017.
42. Stein, C. A. & Chang, Y.-C. (1993). Antisense oligonucleotides as therapeutic agents-is the bullet really magical? Science, 261, 1004-1012.
43. Szczylik, C., Skorski, T., Nicolaides, N. C., Manzella, L., Malaguarnera, L., Venturelli, D., Gewirtz, A. M. & Calabretta, B. (1991). Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides. Science, 253, 562-565.
44. Tabler, M., Homann, M., Tzortzakaki, S. & Sczakiel, G. (1994). A three nucleotide helix I is sufficient for full activity of a hammerhead ribozyme: advantages of an asymmetric design. Nucl. Acids Res. 22, 3958-3965.
45. Tari, A. M., Tucker, S. D., Deisseroth, A. & Lopez-Berestein, G. (1994). Liposomal delivery of methylphosphonate antisense oligodeoxynucleotides in chronic myelogenous leukemia. Blood, 84, 601-607.
46. Thomas, M., Kosciolek, B., Wang, N. & Rowley, P. (1994). Capping of bcr-abl antisense oligonucleotides enhances antiproliferative activity against chronic myeloid leukemia cell lines. Leuk. Res. 18, 401-408.
47. Vaerman, J. L., Lammineur, C., Moureau, P., Lewalle, P., Deldime, F., Blumenfeld, M. & Martiat, P. (1995). BCR-ABL antisense oligodeoxyribonucleotides suppress the growth of leukemic and normal hematopoietic cells by a sequence-specific but nonantisense mechanism. Blood, 86, 3891-3896.
48. Voncken, J. W., van Schaick, H., Kaartinen, V., Deemer, K., Coates, T., Landing, B., Pattengale, P., Dorseuil, O., Bokoch, G. M., Groffen, J. & Heisterkamp, N. (1995). Increased neutrophil respiratory burst in bcr-null mutants. Cell, 80, 719-728.
49. Wagner, E. G. H. & Simons, R. W. (1994). Antisense RNA control in bacteria, phage and plasmids. Annu. Rev. Microbiol. 48, 713-740.
50. Wright, L., Wilson, S. B., Milliken, S., Biggs, J. & Kearney, P. (1993). Ribozyme-mediated cleavage of the bcr/abl transcript expressed in chronic myeloid leukemia. Exp. Hematol. 21, 1714-1718.
51. Zarrinkar, P. P. & Williamson, J. R. (1994). Kinetic intermediates in RNA folding. Science, 265, 918-924.